In order to better characterize the effect of HSD11B1 inhibition on the antitumor immune response in the context of TLR7 stimulation, we tested the impact of HSD11B1 activity on the capacity of mouse dendritic cells to initiate an antitumor immune response against renal cancer cells. Here, HSD11B1 is linked to renal carcinoma.